Want to track ANVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Annovis Bio, Inc. (ANVS) Statistics
Valuation metrics
Market Cap 42.4M
Enterprise value 23.92M
Trailing P/E (ttm) -0.56
Forward P/E -1.92
PEG ratio 0.49
Price/Sales (ttm) -
Price/Book (mrq) -8.81
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.49
Overview
Shares outstanding 28.54M
Float 24.58M
Shares short 4.82M
% Held by insiders 0.14%
% Held by institutions 0.17%
Average volume (10 days) 591.82K
Average volume (90 days) 858.38K
Price summary
52-Week low 0.93
52-Week high 5.5
Beta 1.26
50-Day moving average 1.16
200-Day moving average 1.69
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -2.25%
Return on equity -6.86%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -40.92M
Diluted EPS (ttm) -1.32
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 14.22M
Total cash per share (mrq) 0.5
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.95%
Book value per share (mrq) -0.11
Cash Flow
Cash flow statement -26.77M
Levered free cash flow (LFCF) -28.85M
2026 © Marketlog. All Rights Reserved.
